198 related articles for article (PubMed ID: 19137537)
1. Phenotype and function of neonatal DC.
Willems F; Vollstedt S; Suter M
Eur J Immunol; 2009 Jan; 39(1):26-35. PubMed ID: 19137537
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity of the newborn: basic mechanisms and clinical correlates.
Levy O
Nat Rev Immunol; 2007 May; 7(5):379-90. PubMed ID: 17457344
[TBL] [Abstract][Full Text] [Related]
3. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
[TBL] [Abstract][Full Text] [Related]
4. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
[TBL] [Abstract][Full Text] [Related]
5. Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
Sioud M
Scand J Immunol; 2009 Dec; 70(6):516-25. PubMed ID: 19906192
[TBL] [Abstract][Full Text] [Related]
6. Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
Steinbrink K; Mahnke K; Grabbe S; Enk AH; Jonuleit H
Hum Immunol; 2009 May; 70(5):289-93. PubMed ID: 19217922
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells: functional aspects of glycosylation and lectins.
Erbacher A; Gieseke F; Handgretinger R; Müller I
Hum Immunol; 2009 May; 70(5):308-12. PubMed ID: 19236902
[TBL] [Abstract][Full Text] [Related]
8. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.
Ahlers JD; Belyakov IM
Trends Mol Med; 2009 Jun; 15(6):263-74. PubMed ID: 19487159
[TBL] [Abstract][Full Text] [Related]
9. Immune responses in neonates.
Basha S; Surendran N; Pichichero M
Expert Rev Clin Immunol; 2014 Sep; 10(9):1171-84. PubMed ID: 25088080
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?
Lebre MC; Tak PP
Hum Immunol; 2009 May; 70(5):321-4. PubMed ID: 19236901
[TBL] [Abstract][Full Text] [Related]
11. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
Abediankenari S; Ghasemi M
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):25-30. PubMed ID: 19279356
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic differences in leucocyte populations among healthy preterm and full-term newborns.
Quinello C; Silveira-Lessa AL; Ceccon ME; Cianciarullo MA; Carneiro-Sampaio M; Palmeira P
Scand J Immunol; 2014 Jul; 80(1):57-70. PubMed ID: 24724912
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated pathways in chronic inflammatory arthritis.
Gorman CL; Cope AP
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):221-38. PubMed ID: 18455681
[TBL] [Abstract][Full Text] [Related]
14. Imprinted DC mediate the immune-educating effect of early-life microbial exposure.
Jiao L; Han X; Wang S; Fan Y; Yang M; Qiu H; Yang X
Eur J Immunol; 2009 Feb; 39(2):469-80. PubMed ID: 19180467
[TBL] [Abstract][Full Text] [Related]
15. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
16. The immunoglobulin E-Toll-like receptor network.
Novak N; Bieber T; Peng WM
Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
[TBL] [Abstract][Full Text] [Related]
17. Helping the helpers!
Ma CS; Tangye SG
Immunity; 2009 Jul; 31(1):12-4. PubMed ID: 19604489
[TBL] [Abstract][Full Text] [Related]
18. New perspectives for large-scale repertoire analysis of immune receptors.
Boudinot P; Marriotti-Ferrandiz ME; Pasquier LD; Benmansour A; Cazenave PA; Six A
Mol Immunol; 2008 May; 45(9):2437-45. PubMed ID: 18279958
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells--why can they help and hurt us.
Schäkel K
Exp Dermatol; 2009 Mar; 18(3):264-73. PubMed ID: 19183400
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-based cancer immunotherapies.
Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
